Final Exam: NR565/ NR 565 Advanced Pharmacology
A newly pregnant mother's understanding of hypothyroidism - ANS -Increase dose up to 50% starting in weeks 4-8, can
cause neurophysiological damage
\A1c general goal - ANS -<7%
\Active immunity - ANS -Immune system produces antibodies in response to antigen or vaccine
\Anti-diarrheal associated with gray/black stools and black tongue - ANS -Pepto Bismol
\Anti-diarrheal associated with gray/black stools and black tongue - ANS -Pepto Bismol
\Antidiarrheal contraindicated in children with chickenpox - ANS -Pepto Bismol
\Antidiarrheal contraindicated in children with chickenpox - ANS -Pepto Bismol
\Asthma and COPD management with - ANS -SABA
\Attenuated influenza vaccine recipients - ANS -Individuals >2 yo and less than 50, non-pregnant, and not
immunocompromised
\Attenuated vaccine example - ANS -Measles, mumps, and rubella (MMR) vaccine, varicella (chickenpox) vaccine
\Benefits of LABA use - ANS -Long-term control, fixed schedule
\Benefits of SABA use - ANS -Rescue medication for acute symptoms, not for prolonged prophylaxis
\Biguanide mechanism of action - ANS -Decrease glucose production by the liver
\Black box warning for Reglan - ANS -Tardive Dyskinesia, discontinue at 12 weeks or if movement disorder develops
\Confirmation of diabetes diagnosis - ANS -Fasting plasma glucose ≥126, random plasma glucose ≥200 plus symptoms,
oral glucose tolerance test ≥200, hemoglobin A1c ≥6.5
\Contraindication for DTaP or Tdap vaccine - ANS -History of anaphylactic reaction or encephalopathy within 7 days of
vaccine
\Decongestant examples - ANS -Beclomethasone diproprante, budesonide, fluticasone, triamcinolone
\Decongestant mechanism of action - ANS -Shrink engorged mucous membranes to decrease stuffiness
\Diabetic medications associated with hypoglycemia - ANS -Amylin Analogues, Insulin, Meglitinides, Sulfonylureas
\DPP-4i mechanism of action - ANS -Increase insulin production, inhibit glucagon release
\DPP4-1 examples - ANS -Sitagliptin, saxagliptin
, \DPP4-1 mechanism of action - ANS -Enhance incretin activity, increase insulin release, reduce glucagon release
\Drug class to consider prior to insulin for diabetes - ANS -Metformin
\Drug class with no significant interactions - ANS -Expectorants
\Drug interaction with canagliflozin - ANS -UTI and fungal infection, change medications
\Drug-resistant TB definition - ANS -MDR-TB: resistant to isoniazid and rifampin, XDR-TB: resistant to isoniazid, rifampin,
fluoroquinolones, and injectable second line drugs
\Expectorant mechanism of action - ANS -Encourage expectoration of excessive mucus in the respiratory tract
\Fecal impaction - ANS -Condition when psyllium doesn't produce a bowel movement
\GERD treatment during pregnancy - ANS -Avoid misoprostol, sucralfate is safe
\GLP-1 examples - ANS -Semaglutide, exenatide
\GLP-1 mechanism of action - ANS -Increase insulin production, inhibit glucagon release, increase satiety
\H2 receptor antagonist with CYP450 interactions - ANS -Cimetidine
\H2 receptor antagonist with CYP450 interactions - ANS -Cimetidine
\H2 receptor antagonists contraindicated in older adults - ANS -Ranitidine and Cimetidine
\H2 receptor antagonists examples - ANS -Cimetidine, ranitidine, famotidine, nizatidine
\H2 receptor antagonists examples - ANS -Cimetidine, ranitidine, famotidine, nizatidine
\Hepatitis B vaccine contraindications - ANS -Prior anaphylactic reaction to baker yeasts of Hep B itself
\Herd immunity - ANS -Resistance to an infectious organism due to a large group of immune individuals
\Hyperthyroidism labs - ANS -Decreased TSH, increased T3 & T4
\Hypothyroidism labs - ANS -Increased TSH, decreased T3 & T4
\IBS - ANS -Diagnosis and treatment aided by keeping a diary
\Inactive viral antigen vaccine example - ANS -Poliovirus vaccine, hepatitis A vaccine (HepA), influenza vaccine
\Insulin action - ANS -Regulation of glucose metabolism, promotes glucose and amino acid uptake, synthesis of complex
organic molecules
\Insulin dose calculation - ANS -Calculate TDD, mealtime carbs, ratio, insulin coverage
\Intermittent asthma symptoms - ANS -2 days/week or less, 2 times/month nighttime awakening, SABA use 2 days/week
or less
\Interval to recheck A1c - ANS -2-4 times a year until A1c drops to 7%, then at least every 6 months
\Isoniazid use - ANS -Prevent TB in people exposed
A newly pregnant mother's understanding of hypothyroidism - ANS -Increase dose up to 50% starting in weeks 4-8, can
cause neurophysiological damage
\A1c general goal - ANS -<7%
\Active immunity - ANS -Immune system produces antibodies in response to antigen or vaccine
\Anti-diarrheal associated with gray/black stools and black tongue - ANS -Pepto Bismol
\Anti-diarrheal associated with gray/black stools and black tongue - ANS -Pepto Bismol
\Antidiarrheal contraindicated in children with chickenpox - ANS -Pepto Bismol
\Antidiarrheal contraindicated in children with chickenpox - ANS -Pepto Bismol
\Asthma and COPD management with - ANS -SABA
\Attenuated influenza vaccine recipients - ANS -Individuals >2 yo and less than 50, non-pregnant, and not
immunocompromised
\Attenuated vaccine example - ANS -Measles, mumps, and rubella (MMR) vaccine, varicella (chickenpox) vaccine
\Benefits of LABA use - ANS -Long-term control, fixed schedule
\Benefits of SABA use - ANS -Rescue medication for acute symptoms, not for prolonged prophylaxis
\Biguanide mechanism of action - ANS -Decrease glucose production by the liver
\Black box warning for Reglan - ANS -Tardive Dyskinesia, discontinue at 12 weeks or if movement disorder develops
\Confirmation of diabetes diagnosis - ANS -Fasting plasma glucose ≥126, random plasma glucose ≥200 plus symptoms,
oral glucose tolerance test ≥200, hemoglobin A1c ≥6.5
\Contraindication for DTaP or Tdap vaccine - ANS -History of anaphylactic reaction or encephalopathy within 7 days of
vaccine
\Decongestant examples - ANS -Beclomethasone diproprante, budesonide, fluticasone, triamcinolone
\Decongestant mechanism of action - ANS -Shrink engorged mucous membranes to decrease stuffiness
\Diabetic medications associated with hypoglycemia - ANS -Amylin Analogues, Insulin, Meglitinides, Sulfonylureas
\DPP-4i mechanism of action - ANS -Increase insulin production, inhibit glucagon release
\DPP4-1 examples - ANS -Sitagliptin, saxagliptin
, \DPP4-1 mechanism of action - ANS -Enhance incretin activity, increase insulin release, reduce glucagon release
\Drug class to consider prior to insulin for diabetes - ANS -Metformin
\Drug class with no significant interactions - ANS -Expectorants
\Drug interaction with canagliflozin - ANS -UTI and fungal infection, change medications
\Drug-resistant TB definition - ANS -MDR-TB: resistant to isoniazid and rifampin, XDR-TB: resistant to isoniazid, rifampin,
fluoroquinolones, and injectable second line drugs
\Expectorant mechanism of action - ANS -Encourage expectoration of excessive mucus in the respiratory tract
\Fecal impaction - ANS -Condition when psyllium doesn't produce a bowel movement
\GERD treatment during pregnancy - ANS -Avoid misoprostol, sucralfate is safe
\GLP-1 examples - ANS -Semaglutide, exenatide
\GLP-1 mechanism of action - ANS -Increase insulin production, inhibit glucagon release, increase satiety
\H2 receptor antagonist with CYP450 interactions - ANS -Cimetidine
\H2 receptor antagonist with CYP450 interactions - ANS -Cimetidine
\H2 receptor antagonists contraindicated in older adults - ANS -Ranitidine and Cimetidine
\H2 receptor antagonists examples - ANS -Cimetidine, ranitidine, famotidine, nizatidine
\H2 receptor antagonists examples - ANS -Cimetidine, ranitidine, famotidine, nizatidine
\Hepatitis B vaccine contraindications - ANS -Prior anaphylactic reaction to baker yeasts of Hep B itself
\Herd immunity - ANS -Resistance to an infectious organism due to a large group of immune individuals
\Hyperthyroidism labs - ANS -Decreased TSH, increased T3 & T4
\Hypothyroidism labs - ANS -Increased TSH, decreased T3 & T4
\IBS - ANS -Diagnosis and treatment aided by keeping a diary
\Inactive viral antigen vaccine example - ANS -Poliovirus vaccine, hepatitis A vaccine (HepA), influenza vaccine
\Insulin action - ANS -Regulation of glucose metabolism, promotes glucose and amino acid uptake, synthesis of complex
organic molecules
\Insulin dose calculation - ANS -Calculate TDD, mealtime carbs, ratio, insulin coverage
\Intermittent asthma symptoms - ANS -2 days/week or less, 2 times/month nighttime awakening, SABA use 2 days/week
or less
\Interval to recheck A1c - ANS -2-4 times a year until A1c drops to 7%, then at least every 6 months
\Isoniazid use - ANS -Prevent TB in people exposed
